Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-month pilot study of bimatoprost + timolol fixed combination versus latanoprost in treatment-naïve open-angle glaucoma
2009-012799-28Phase 4Completed
- Sponsor
- Allergan
- Start
- Nov 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in open-angle glaucoma (OAG) comparing Bimatoprost + timolol fixed combination with Latanoprost (2 arms). Primary endpoint: Mean change from baseline average intraocular pressure at 3 months. Started Nov 2009; status: completed.
02
Drugs
bimatoprosttimolollatanoprost
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2009-012799-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012799-28.